ALX ONCOLOGY HOLDINGS INC

ALXO

ALX ONCOLOGY HOLDINGS INC

ALXO

Insider Sentiment (TTM):

Last Purchase:2026-02-02Last Sale:2026-03-19Shares Purchased (TTM):3,255,876Shares Sold (TTM):17,704

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:93,099,363Shares Outstanding:104,573,657Institutional Ownership Pct.:89.03%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	23	32	16	23	19	21	18	16	16	14	22	20
Short Term Investments	116	108	28	37	60	77	110	132	141	143	160	170
Prepaid Expense And Other Assets Current	5	5	6	6	6	5	7	7	12	10	6	9
Assets Current	143	146	51	67	85	103	134	156	169	168	189	199
Property Plant And Equipment Net	0	1	1	1	1	3	3	3	3	3	4	4
Long Term Investments	15	29	3	6	4	9	4	14	29	27	35	6
Other Assets Noncurrent	2	3	4	9	4	7	7	13	13	14	15	11
Assets	161	178	59	83	95	121	148	186	215	213	243	220
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	3	4	5	7	5	4	4	8	8	6	9	13
Other Liabilities Current	-	-	0	0	0	0	0	0	0	0	1	0
Long Term Debt Current	0	5	5	4	3	2	0	-	-	-	-	-
Accrued Liabilities And Other Liabilities	12	11	14	17	11	13	13	24	30	26	27	22
Liabilities Current	15	20	25	28	19	19	19	32	38	32	36	35
Long Term Debt Noncurrent	10	3	5	6	7	8	9	10	10	10	10	10
Other Liabilities Noncurrent	0	4	4	4	5	6	6	7	7	7	7	7
Liabilities	25	27	33	38	31	33	34	49	55	48	53	51
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	895	892	749	745	742	740	734	728	721	686	676	610
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	0	0	0	1	-0	0	0	-0
Retained Earnings Accumulated Deficit	-759	-741	-723	-700	-678	-652	-621	-592	-561	-522	-486	-441
Stockholders Equity	136	151	26	45	64	88	114	137	159	164	190	169
Liabilities And Stockholders Equity	161	178	59	83	95	121	148	186	215	213	243	220
Common Stock Par Or Stated Value Per Share	-	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000
Common Stock Shares Issued	138	135	54	54	54	53	53	53	52	50	50	41
Shares Outstanding	138	135	54	54	54	53	53	53	52	50	50	41

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-8.65%	-1.92%	-2.40%	-	-	-	-	-	-	-	-	-
2025	5.65%	-11.74%	14.35%	98.37%	254.47%	150.41%	-0.72%	-3.62%	1.45%	-7.51%	-20.66%	-10.80%
2024	-37.29%	-64.42%	-64.31%	-24.21%	-33.33%	-42.46%	-1.99%	7.28%	0.33%	-50.00%	-58.63%	-64.58%
2023	-	-	-	-10.32%	-4.76%	32.64%	45.43%	49.35%	74.38%	-31.34%	3.82%	-18.90%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	9.71	7.21	2.07	2.40	4.52	5.47	7.26	4.82	4.39	5.21	5.24	5.66
Quick Ratio	9.35	6.95	1.82	2.19	4.21	5.22	6.91	4.59	4.08	4.89	5.08	5.41
Working Capital	128.68M	125.39M	26.17M	38.79M	66.41M	83.79M	115.85M	123.56M	130.26M	135.64M	152.66M	163.93M
Leverage & Debt
Debt to Equity	0.18	0.18	1.27	0.85	0.48	0.37	0.30	0.36	0.35	0.30	0.28	0.30
Interest Coverage TTM	-58.67	-59.70	-64.93	-67.81	-72.24	-79.93	-82.40	-93.11	-108.66	-109.56	-108.80	-111.86
Debt Ratio	0.15	0.15	0.56	0.46	0.32	0.27	0.23	0.26	0.26	0.23	0.22	0.23
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.60	-0.85	-1.90	-2.02	-2.18	-2.44	-2.58	-2.87	-3.31	-3.32	-3.74	-3.55
Free Cash Flow Per Share TTM	-0.57	-0.75	-1.57	-1.36	-1.52	-2.04	-2.35	-2.47	-2.64	-2.87	-3.12	-2.81
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-30.61%	-31.65%	-24.59%	-28.55%	-32.00%	-21.77%	-16.14%	3.50%	31.50%	28.71%	30.23%	20.49%
EPS Growth (1Y)	-72.66%	-65.13%	-26.67%	-29.72%	-34.06%	-26.52%	-30.91%	-19.18%	3.71%	4.93%	23.29%	19.31%
Valuation Metrics
P/E TTM	-3.47	-2.36	-0.60	-0.91	-0.19	-0.26	-0.65	-0.63	-1.82	-3.36	-3.98	-1.35
P/B TTM	2.06	1.39	2.33	2.19	0.34	0.38	0.77	0.70	1.96	3.40	3.37	1.17
Market Cap	280.77M	209.67M	60.63M	98.05M	22.18M	33.24M	87.13M	95.90M	312.54M	558.85M	640.09M	197.51M
Enterprise Value	267.53M	185.83M	53.94M	84.72M	12.85M	22.53M	79.47M	89.57M	306.71M	554.44M	627.32M	187.44M
Calculated Values
Free Cash Flow TTM	-77.04M	-78.36M	-84.38M	-72.73M	-81.11M	-109.01M	-122.36M	-130.08M	-137.02M	-143.81M	-134.24M	-115.48M
Net Debt	-13.25M	-23.84M	-6.69M	-13.33M	-9.33M	-10.71M	-7.66M	-6.33M	-5.83M	-4.40M	-12.77M	-10.08M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-19Sale

Owner: Pinto, Shelly

Title: SVP, FINANCE AND CAO

Shares: 903

Price/Share: $2.17

Value: $1,959.51

Shares Owned: 86,805

Relationship: Officer

Ownership: Direct

2026-03-19Sale

Owner: Lettmann, Jason

Title: CHIEF EXECUTIVE OFFICER

Shares: 12,311

Price/Share: $2.17

Value: $26,714.87

Shares Owned: 293,609

Relationship: Director,Officer

Ownership: Direct

2026-02-18Sale

Owner: Pinto, Shelly

Title: SVP, FINANCE AND CAO

Shares: 565

Price/Share: $2.27

Value: $1,282.55

Shares Owned: 87,708

Relationship: Officer

Ownership: Direct

2026-02-02Purchase

Owner: Goodman, Corey S

Title: -

Shares: 3,184,713

Price/Share: $1.57

Value: $4,999,999.41

Shares Owned: 8,453,038

Relationship: Director,TenPercentOwner

Ownership: Indirect

2026-01-06Sale

Owner: Pinto, Shelly

Title: SVP, FINANCE AND CAO

Shares: 3,925

Price/Share: $1.11

Value: $4,356.75

Shares Owned: 88,273

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-19	Pinto, Shelly	Officer	SVP, FINANCE AND CAO	Direct	Sale	903	2.17	$1,959.51	86,805	4
2026-03-19	Lettmann, Jason	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	12,311	2.17	$26,714.87	293,609	4
2026-02-18	Pinto, Shelly	Officer	SVP, FINANCE AND CAO	Direct	Sale	565	2.27	$1,282.55	87,708	4
2026-02-02	Goodman, Corey S	Director,TenPercentOwner	-	Indirect	Purchase	3,184,713	1.57	$4,999,999.41	8,453,038	4
2026-01-06	Pinto, Shelly	Officer	SVP, FINANCE AND CAO	Direct	Sale	3,925	1.11	$4,356.75	88,273	4
2025-09-17	Lettmann, Jason	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Purchase	71,163	1.08	$76,856.04	305,121	4
2025-08-18	Shantharam, Harish	Officer	Chief Financial Officer	Direct	Purchase	75,000	0.78	$58,500.00	75,000	4
2025-08-15	Lettmann, Jason	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	2,382	0.64	$1,524.48	212,888	4
2025-08-15	Pinto, Shelly	Officer	SVP, FINANCE AND CAO	Direct	Sale	611	0.64	$391.04	89,198	4
2025-07-07	Pinto, Shelly	Officer	SVP, FINANCE AND CAO	Direct	Sale	2,011	0.45	$904.95	86,809	4
2025-06-30	Pinto, Shelly	Officer	SVP, FINANCE AND CAO	Direct	Sale	1,532	0.43	$658.76	88,820	4
2025-02-19	Pons, Jaume	Officer	PRESIDENT & CSO	Direct	Sale	1,326	1.15	$1,524.90	579,388	4
2025-02-19	Pinto, Shelly	Officer	SVP, FINANCE AND CAO	Direct	Sale	550	1.15	$632.50	87,352	4
2025-02-19	Lettmann, Jason	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	2,159	1.15	$2,482.85	170,270	4
2025-01-06	Pinto, Shelly	Officer	Interim CFO	Direct	Sale	2,221	1.80	$3,997.80	87,902	4
2024-12-30	Pons, Jaume	Officer	PRESIDENT & CSO	Direct	Sale	10,796	1.58	$17,057.68	580,714	4
2024-12-30	Pinto, Shelly	Officer	Interim CFO	Direct	Sale	1,426	1.58	$2,253.08	90,123	4
2024-12-02	Hemrajani, Rekha	Director	-	Direct	Purchase	30,000	1.55	$46,500.00	33,000	4
2024-08-14	Pinto, Shelly	Officer	SVP, FINANCE AND CAO	Direct	Sale	564	2.58	$1,455.12	91,549	4
2024-08-14	Randolph, Sophia	Officer	CHIEF MEDICAL OFFICER	Direct	Sale	1,365	2.58	$3,521.70	325,711	4
2024-08-14	Pons, Jaume	Officer	PRESIDENT & CSO	Direct	Sale	1,937	2.58	$4,997.46	591,510	4
2024-07-11	Pons, Jaume	Director,Officer	PRESIDENT & CSO	Direct	Sale	20,000	7.90	$158,000.00	593,447	4
2024-07-05	Pinto, Shelly	Officer	SVP, FINANCE AND CAO	Direct	Sale	1,823	5.50	$10,026.50	92,113	4
2024-07-01	Pinto, Shelly	Officer	SVP, FINANCE AND CAO	Direct	Sale	1,373	5.82	$7,990.86	93,936	4
2024-07-01	Randolph, Sophia	Director,Officer	CHIEF MEDICAL OFFICER	Direct	Sale	3,273	5.82	$19,048.86	327,076	4
2024-07-01	Pons, Jaume	Director,Officer	PRESIDENT & CSO	Direct	Sale	10,758	5.82	$62,611.56	593,447	4
2024-06-13	Garcia, Peter S	Officer	CHIEF FINANCIAL OFFICER	Direct	Purchase	12,000	8.53	$102,360.00	122,348	4/A
2024-06-04	Pons, Jaume	Director,Officer	PRESIDENT & CSO	Direct	Sale	20,000	8.43	$168,600.00	604,205	4
2024-05-13	Randolph, Sophia	Director,Officer	CHIEF MEDICAL OFFICER	Direct	Sale	12,000	16.24	$194,880.00	330,349	4
2024-05-06	Pons, Jaume	Director,Officer	PRESIDENT & CSO	Direct	Sale	20,000	15.92	$318,400.00	604,205	4
2024-04-16	Pons, Jaume	Director,Officer	PRESIDENT & CSO	Direct	Sale	50,000	14.20	$710,000.00	604,205	4
2024-04-04	Pons, Jaume	Director,Officer	PRESIDENT & CSO	Direct	Sale	20,000	11.15	$223,000.00	628,359	4
2024-03-14	Lettmann, Jason	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Purchase	4,400	11.31	$49,764.00	171,620	4
2024-01-04	Pinto, Shelly	Officer	SVP, Finance and CAO	Direct	Sale	2,717	13.60	$36,951.20	78,591	4
2023-12-29	Pinto, Shelly	Officer	SVP, Finance and CAO	Direct	Sale	1,631	15.04	$24,530.24	81,308	4
2023-12-29	Pons, Jaume	Director,Officer	President & CSO	Direct	Sale	7,179	15.04	$107,972.16	618,359	4
2023-12-29	Garcia, Peter S	Officer	Chief Financial Officer	Direct	Sale	1,893	15.04	$28,470.72	85,348	4
2023-12-29	Randolph, Sophia	Director,Officer	Chief Medical Officer	Direct	Sale	3,128	15.04	$47,045.12	312,349	4
2023-07-06	Pinto, Shelly	Officer	VP, Finance and CAO	Direct	Sale	7,345	6.52	$47,889.40	55,713	4
2023-06-30	Pons, Jaume	Director,Officer	President & CEO	Direct	Sale	3,208	7.34	$23,546.72	536,538	4
2023-06-30	Pinto, Shelly	Officer	VP, Finance and CAO	Direct	Sale	466	7.34	$3,420.44	63,058	4
2023-06-30	Randolph, Sophia	Director,Officer	Chief Medical Officer	Direct	Sale	1,605	7.34	$11,780.70	281,477	4
2023-06-30	Garcia, Peter S	Officer	Chief Financial Officer	Direct	Sale	887	7.34	$6,510.58	54,738	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

89.03%

Inst. Shares: 93,099,363

Shares Outstanding: 104,573,657

2025-12-31

51.58%

Inst. Shares: 27,676,704

Shares Outstanding: 53,658,399

2025-09-30

49.26%

Inst. Shares: 26,393,828

Shares Outstanding: 53,577,066

2025-06-30

51.75%

Inst. Shares: 27,657,004

Shares Outstanding: 53,445,631

2025-03-31

62.25%

Inst. Shares: 33,215,351

Shares Outstanding: 53,359,338

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	93,099,363	104,573,657	89.03%
2025-12-31	27,676,704	53,658,399	51.58%
2025-09-30	26,393,828	53,577,066	49.26%
2025-06-30	27,657,004	53,445,631	51.75%
2025-03-31	33,215,351	53,359,338	62.25%
2024-12-31	39,763,253	52,174,904	76.21%
2024-09-30	44,788,978	52,693,878	85.00%
2024-06-30	48,397,190	51,831,157	93.37%
2024-03-31	45,084,242	50,120,758	89.95%
2023-12-31	44,763,101	42,987,767	104.13%
2023-09-30	32,967,344	41,147,938	80.12%
2023-06-30	33,490,492	40,875,457	81.93%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

ALX ONCOLOGY HOLDINGS INC (ALXO) — SEC Financial Statements & Analysis

ALX ONCOLOGY HOLDINGS INC (ALXO) is a pharmaceutical preparations company, incorporated in DE. ALX ONCOLOGY HOLDINGS INC trades on Nasdaq as: ALXO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), ALX ONCOLOGY HOLDINGS INC reported a Debt-to-Equity ratio of 0.18x, a Price-to-Book (P/B) ratio of 2.06x (TTM), at a market cap of $280.77M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.18x
P/B TTM: 2.06x
Market Cap: $280.77M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ALX ONCOLOGY HOLDINGS INC in?

ALX ONCOLOGY HOLDINGS INC (ALXO) operates in the Pharmaceutical Preparations industry.

What is ALXO's market cap?

ALX ONCOLOGY HOLDINGS INC (ALXO) has a market capitalization of $280.77M as of 2026-06-30.

What exchange does ALXO trade on?

ALX ONCOLOGY HOLDINGS INC (ALXO) trades on the Nasdaq.

Where is ALX ONCOLOGY HOLDINGS INC incorporated?

ALX ONCOLOGY HOLDINGS INC is incorporated in DE.